BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//California Life Sciences - ECPv6.17.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.califesciences.org
X-WR-CALDESC:Events for California Life Sciences
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260605T084500
DTEND;TZID=America/Los_Angeles:20260605T173000
DTSTAMP:20260506T220754Z
CREATED:20260506T220754Z
LAST-MODIFIED:20260506T220754Z
UID:10001083-1780649100-1780680600@www.califesciences.org
SUMMARY:Clinical Trial Planning and Conduct in Oncology: Fundamentals\, Strategies and Best Practices
DESCRIPTION:Oncology is the largest therapeutic area in drug development\, accounting for nearly half of the biopharmaceutical industry’s $200 billion per year investment in R&D. Because oncology clinical development is exceptionally competitive\, costly\, and fast-paced\, mastering its unique complexities is essential for success. Join us for this full day workshop intended to guide you through the fundamentals of oncology clinical trials—from initial strategic planning to final regulatory approval. This workshop is intended for professionals with little to no prior experience who seek to build or enhance collaborations with clinical development teams or transition into an oncology-focused career. Our speakers are seasoned experts from pharma and biotech companies who will describe core concepts and provide practical real-world examples to facilitate deep understanding. \nTopics: \n\nEarly and late clinical development strategies\, study design\, protocol development\nPatient safety\, pharmacovigilance\, and regulatory reporting requirements\nBiostatistics\, biomarkers\, and dose optimization\nTrial operations\, data management\, and quality assurance\nRegulatory considerations\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/clinical-trial-planning-and-conduct-in-oncology/
LOCATION:Crowne Plaza Hotel\, Foster City\, 1221 Chess Dr\, Foster City\, CA\, 94404\, United States
CATEGORIES:Industry Events
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260430T084500
DTEND;TZID=America/Los_Angeles:20260430T173000
DTSTAMP:20260401T221727Z
CREATED:20260401T221727Z
LAST-MODIFIED:20260401T221727Z
UID:10001051-1777538700-1777570200@www.califesciences.org
SUMMARY:Vendor Scientific Highlights Symposium: DMPK & Bioanalytical Technologies and Case Studies
DESCRIPTION:This symposium will highlight emerging strategies and practical considerations in drug metabolism\, bioanalysis\, and translational sciences for novel therapeutic modalities. As the industry moves beyond traditional small molecules toward increasingly complex platforms — including oligonucleotides\, peptides\, and antibody–drug conjugates (ADCs) — there is a growing need for fit-for-purpose ADME characterization and advanced analytical approaches. \nExpert speakers from industry will share real-world case studies and methodological advances addressing in vitro ADME characterization and innovative LC–MS bioanalytical strategies across a range of therapeutic modalities. Topics will include modality-specific challenges\, comparison of novel modalities with small molecules\, and lessons learned from both cleavable and non-cleavable ADC linker systems. \nThis event will provide valuable insights for scientists working in DMPK\, bioanalysis\, and translational research\, offering practical perspectives on how evolving analytical technologies are being applied to support drug discovery and development in a rapidly changing therapeutic landscape. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/vendor-scientific-highlights-symposium/
LOCATION:Crowne Plaza Hotel\, Foster City\, 1221 Chess Dr\, Foster City\, CA\, 94404\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260317T084500
DTEND;TZID=America/Los_Angeles:20260317T173000
DTSTAMP:20260202T165726Z
CREATED:20260202T165726Z
LAST-MODIFIED:20260202T165726Z
UID:10000977-1773737100-1773768600@www.califesciences.org
SUMMARY:Oncology Preclinical Models and Pharmacology Studies for Translational Research: Fundamentals\, Applications and Case Studies
DESCRIPTION:Developing effective cancer therapies remains a major challenge\, with low translational success despite advances in molecular oncology. A key barrier is the limited predictive power of traditional preclinical models and the need for robust pharmacological evaluation. \nThis workshop addresses these challenges by exploring preclinical models and pharmacology strategies essential for oncology drug development. With the rise of complex modalities including immunotherapies\, ADCs\, and cell-based treatments\, refining preclinical evaluation is critical to improve clinical translation. \nKey Topics\n\nPreclinical Development – Target validation\, mechanism of action\, efficacy profiling.\nIn Vivo Models – Xenografts\, GEMMs: strengths and limitations.\nPharmacokinetics – ADME\, PK/PD modeling for oncology agents.\nPDX Models – Preserving tumor heterogeneity for predictive insights.\n3D Cultures – Spheroids and organoids for physiologic relevance.\nOrgan-on-Chip – Microfluidic systems for dynamic tumor modeling.\nAI/ML Applications – Predictive modeling\, biomarker discovery\, patient stratification.\n\nREGISTER»
URL:https://www.califesciences.org/event/oncology-preclinical-models-and-pharmacology-studies-for-translational-research-fundamentals/
LOCATION:Crowne Plaza Hotel\, Foster City\, 1221 Chess Dr\, Foster City\, CA\, 94404\, United States
CATEGORIES:Industry Events,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260317
DTEND;VALUE=DATE:20260320
DTSTAMP:20260312T160326Z
CREATED:20260312T160326Z
LAST-MODIFIED:20260312T160326Z
UID:10001035-1773705600-1773964799@www.califesciences.org
SUMMARY:BSMA 18th Annual Summit 2026
DESCRIPTION:The Bio Supply Management Alliance (BSMA) invites global leaders\, innovators\, and changemakers in biopharma supply chain management to join the 18th Annual BSMA Conference — the industry’s premier gathering for advancing the future of life sciences supply chains. \nWith more than 200 companies represented and over 350 subject matter experts\, executives\, service providers\, and technology leaders\, this is your opportunity to shape and advance the way therapies are delivered to patients worldwide. \n\nCLS members receive a 25% discount to attend the full conference. Contact your account manager or reach out to bd@califesciences.org for more information. \n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/bsma-18th-annual-summit-2026/
LOCATION:Crowne Plaza Hotel\, Foster City\, 1221 Chess Dr\, Foster City\, CA\, 94404\, United States
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260219T084500
DTEND;TZID=America/Los_Angeles:20260219T173000
DTSTAMP:20251219T193456Z
CREATED:20251219T193456Z
LAST-MODIFIED:20251219T193456Z
UID:10000967-1771490700-1771522200@www.califesciences.org
SUMMARY:CMC of Protein and Antibody Therapeutics: Fundamentals\, Best Practices\, and Regulatory Strategies
DESCRIPTION:This workshop will cover all key functions of Chemistry\, Manufacturing and Control (CMC) of recombinant protein and antibody therapeutics. Designed for both experts seeking cross-functional insights and new entrants from academia or industry\, it will provide a clear understanding of how all CMC functions connect. The attendees will gain a knowledge of the current best practices and emerging trends across the CMC landscape—from process and analytical development to formulation\, manufacturing and regulatory considerations. Subject-matter experts will share their real-world experiences and provide their perspectives on the future practices. Join us to strengthen your CMC knowledge\, broaden your perspective\, and network with peers shaping the future of biotherapeutic development \nOutline: \n\nGeneration of production cell line and cell banking\,\nUpstream Process Development\,\nDownstream Process Development\,\nAnalytical Development\,\nDrug substance production and scale up\,\nFormulation and drug product development\,\nRegulatory CMC and Quality Assurance.\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/cmc-of-protein-and-antibody-therapeutics/
LOCATION:Crowne Plaza Hotel\, Foster City\, 1221 Chess Dr\, Foster City\, CA\, 94404\, United States
CATEGORIES:Industry Events,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
END:VCALENDAR